Review
Published on 22 Oct 2014
Axon growth inhibition by RhoA/ROCK in the central nervous system
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00338
- 35,836 views
- 252 citations
Type at least 3 characters
1,063 articles
articles
Original Research
Published on 07 Oct 2014
The rho kinase inhibitor Y-27632 improves motor performance in male SOD1G93A mice
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00304
- 11,626 views
- 33 citations
Original Research
Published on 06 Oct 2014
Change of cystine/glutamate antiporter expression in ethanol-dependent rats
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00311
- 5,463 views
- 18 citations
Review
Published on 18 Sep 2014
Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00288
- 15,417 views
- 27 citations
General Commentary
Published on 02 Sep 2014
Why lithium studies for ALS treatment should not be halted prematurely
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00267
- 6,020 views
- 5 citations
Review
Published on 28 Aug 2014
ROCK inhibition as a therapy for spinal muscular atrophy: understanding the repercussions on multiple cellular targets
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00271
- 11,804 views
- 36 citations
General Commentary
Published on 19 Aug 2014
Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00254
- 4,178 views
- 3 citations
Opinion
Published on 17 Jul 2014
Role of glutamate transporter 1 in the attenuation of alcohol intake
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00200
- 5,155 views
- 6 citations
Review
Published on 24 Jun 2014
P2X4 receptors (P2X4Rs) represent a novel target for the development of drugs to prevent and/or treat alcohol use disorders
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00176
- 11,377 views
- 51 citations
Original Research
Published on 13 Jun 2014
CamKII inhibitors reduce mitotic instability, connexon anomalies and progression of the in vivo behavioral phenotype in transgenic animals expressing a mutated Gjb1 gene
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00151
- 6,109 views
- 10 citations
Editorial
Published on 12 Jun 2014
Opportunities and perspectives for developing orexin receptor antagonists
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00158
- 5,580 views
- 4 citations
Review
Published on 06 Jun 2014
GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00140
- 17,811 views
- 94 citations
Review
Published on 03 Jun 2014
Targeting central melanocortin receptors: a promising novel approach for treating alcohol abuse disorders
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00128
- 8,787 views
- 30 citations
Original Research
Published on 27 May 2014
Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL/6J mice
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00129
- 8,755 views
- 67 citations
Review
Published on 22 May 2014
Advances in non-dopaminergic treatments for Parkinson's disease
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00113
- 27,646 views
- 89 citations
Original Research
Published on 20 May 2014
Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortex
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00107
- 6,157 views
- 7 citations
Review
Published on 06 May 2014
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00057
- 20,637 views
- 62 citations
Hypothesis and Theory
Published on 08 Apr 2014
The EEG as an index of neuromodulator balance in memory and mental illness
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00063
- 114,911 views
- 41 citations
Review
Published on 25 Feb 2014
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00036
- 21,349 views
- 84 citations
Original Research
Published on 25 Feb 2014
Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00033
- 10,424 views
- 89 citations
Original Research
Published on 14 Feb 2014
Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00028
- 10,950 views
- 68 citations
Mini Review
Published on 13 Feb 2014
Orexin 1 receptor antagonists in compulsive behaviour and anxiety: possible therapeutic use.
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00026
- 19,007 views
- 61 citations
Review
Published on 12 Feb 2014
Orexin, cardio-respiratory function, and hypertension
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00022
- 12,058 views
- 46 citations
Original Research
Published on 11 Feb 2014
Orexin A and orexin receptor 1 axonal traffic in dorsal roots at the CNS/PNS interface
in Neuropharmacology
Frontiers in Neuroscience
doi 10.3389/fnins.2014.00020
- 8,233 views
- 11 citations